Morgan Stanley Xoma Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Xoma Corp stock. As of the latest transaction made, Morgan Stanley holds 1,544,967 shares of XOMA stock, worth $44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,544,967

Previous 1,122,289 37.66%

Holding current value

$44 Million

Previous $22.4 Million 74.06%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$18.76 - $27.49 $7.93 Million - $11.6 Million	422,678 Added 37.66%	1,544,967 $38.9 Million
Q1 2025 May 15, 2025	BUY	$19.93 - $28.12 $16 Million - $22.6 Million	804,970 Added 253.68%	1,122,289 $22.4 Million
Q4 2024 Feb 14, 2025	BUY	$25.11 - $33.88 $3.38 Million - $4.56 Million	134,467 Added 73.54%	317,319 $8.34 Million
Q3 2024 May 14, 2025	BUY	$23.1 - $29.85 $363,501 - $469,719	15,736 Added 9.42%	182,852 $4.84 Million
Q3 2024 Nov 14, 2024	BUY	$23.1 - $29.85 $363,501 - $469,719	15,736 Added 9.42%	182,852 $4.84 Million
Q2 2024 May 14, 2025	SELL	$22.31 - $26.7 $3.35 Million - $4.01 Million	-150,203 Reduced 47.34%	167,116 $3.96 Million
Q2 2024 Oct 17, 2024	BUY	$22.31 - $26.7 $176,985 - $211,811	7,933 Added 4.98%	167,116 $3.96 Million
Q2 2024 Aug 14, 2024	BUY	$22.31 - $26.7 $176,985 - $211,811	7,933 Added 4.98%	167,116 $3.96 Million
Q1 2024 Oct 17, 2024	SELL	$19.1 - $26.32 $151,520 - $208,796	-7,933 Reduced 4.75%	159,183 $3.83 Million
Q1 2024 Aug 16, 2024	BUY	$19.1 - $26.32 $2.74 Million - $3.78 Million	143,636 Added 923.88%	159,183 $3.83 Million
Q1 2024 May 15, 2024	BUY	$19.1 - $26.32 $2.74 Million - $3.78 Million	143,636 Added 923.88%	159,183 $3.83 Million
Q4 2023 Aug 16, 2024	SELL	$13.82 - $19.13 $2.09 Million - $2.9 Million	-151,569 Reduced 90.7%	15,547 $287,000
Q4 2023 Feb 13, 2024	BUY	$13.82 - $19.13 $131,911 - $182,595	9,545 Added 159.03%	15,547 $287,000
Q3 2023 Nov 15, 2023	SELL	$14.02 - $17.71 $203,261 - $256,759	-14,498 Reduced 70.72%	6,002 $84,000
Q2 2023 Aug 14, 2023	SELL	$17.0 - $21.58 $132,005 - $167,568	-7,765 Reduced 27.47%	20,500 $387,000
Q1 2023 May 15, 2023	SELL	$18.01 - $23.12 $391,591 - $502,698	-21,743 Reduced 43.48%	28,265 $596,000
Q4 2022 Feb 14, 2023	BUY	$16.0 - $25.45 $2,512 - $3,995	157 Added 0.31%	50,008 $920,000
Q3 2022 Nov 14, 2022	BUY	$15.9 - $29.56 $78,371 - $145,701	4,929 Added 10.97%	49,851 $893,000
Q2 2022 Oct 27, 2022	BUY	$17.05 - $28.22 $719,237 - $1.19 Million	42,184 Added 1540.69%	44,922 $1 Million
Q2 2022 Aug 15, 2022	BUY	$17.05 - $28.22 $719,237 - $1.19 Million	42,184 Added 1540.69%	44,922 $1 Million
Q1 2022 Oct 27, 2022	SELL	$19.62 - $29.61 $827,650 - $1.25 Million	-42,184 Reduced 93.9%	2,738 $76,000
Q1 2022 May 13, 2022	SELL	$19.62 - $29.61 $30,293 - $45,717	-1,544 Reduced 36.06%	2,738 $76,000
Q4 2021 Feb 14, 2022	SELL	$20.04 - $27.57 $112,364 - $154,584	-5,607 Reduced 56.7%	4,282 $89,000
Q3 2021 Nov 15, 2021	BUY	$23.51 - $34.79 $232,490 - $344,038	9,889 New	9,889 $245,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

6.97M

Call Options Held

Put Options Held

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $326M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account